NRSN icon

NeuroSense Therapeutics

8 hedge funds and large institutions have $304K invested in NeuroSense Therapeutics in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$129K
2 +$35.6K
3 +$11.7K

Top Sellers

1 -$81.9K
2 -$10.1K
3 -$10K
4
Morgan Stanley
Morgan Stanley
New York
-$2.73K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$129K
2
$91K
3
$35.6K
4
$21.8K
5
$21.7K
6
$2.73K
7
$2K
8
$98
9
10